Today's Change
+1.94%
AI Sentiment
63%
Sector AnalysisLive data
Materials Sector Outlook
The Materials sector is up 1.94% today with bullish sentiment across 9 recent news articles. Top movers include $CDTTW (+65.33%), $ERNAW (+63.87%), $TMCWW (+60.68%).
Bullish Factors
- No strong bullish signals detected
Risk Factors
- No strong bearish signals detected
Stocks in Materials
217 stocks| Symbol | Company | Change |
|---|---|---|
| $BFRIW | Biofrontera Inc - Warrants (27/10/2026) | +37.24% |
| $NBY | NovaBay Pharmaceuticals, Inc. | +0.00% |
| $AIMDW | Ainos Inc - Warrants (29/07/2027) | -24.11% |
| $KTTAW | Pasithea Therapeutics Corp - Warrants (11/08/2026) | -1.23% |
| $HUMAW | Humacyte Inc - Warrants (27/08/2026) | +5.13% |
| $BIVIW | BioVie Inc Warrant | +9.38% |
| $REVBW | Revelation Biosciences Inc - Warrants(10/01/2027) | +0.00% |
| $SRZNW | Surrozen Inc - Warrants (01/08/2026) | +5.00% |
| $BCTXZ | BriaCell Therapeutics Corp Warrant | -13.56% |
| $VACHW | Voyager Acquisition Corp - Warrants (16/05/2031) | -1.91% |
| $CITR | General Enterprise Ventures Inc | +3.17% |
| $JSPRW | Jasper Therapeutics Inc - Warrants (24/09/2026) | -15.64% |
| $ANABV | AnaptysBio Inc | +0.00% |
| $SCLXW | Scilex Holding Company - Warrants (10/11/2027) | -6.43% |
| $RVMDW | Revolution Medicines Inc - Warrants (17/12/2026) | +4.86% |
Materials News
808 articlesGlobeNewswire Inc.26d ago
Pacira Presents Real-World Data on EXPAREL® Showing Lower Total Healthcare Costs in Outpatient Total Hip and Knee Arthroplasty Procedures
GlobeNewswire Inc.26d ago
NRx Pharmaceuticals (Nasdaq:NRXP) Announces Appointment of Glenn Tyson as the Company’s first Chief Commercial Officer
GlobeNewswire Inc.26d ago
Spyre Announces Potential Best-in-Class SPY001 Part A Induction Results from SKYLINE Trial in Moderate-to-Severe Ulcerative Colitis Patients
GlobeNewswire Inc.26d ago
Alpha Thalassemia (US, EU4, UK, and Japan) Market Insights, Epidemiology, and Forecasts 2022-2025 & 2025-2036
GlobeNewswire Inc.27d ago
ROSEN, A LEADING AND RANKED FIRM, Encourages Nektar Therapeutics Investors to Secure Counsel Before Important Deadline in Securities Class Action - NKTR
GlobeNewswire Inc.27d ago
Nxera Pharma’s Partner Neurocrine Biosciences Doses First Patient in Phase 2 Trial of NBI-1117570 for Adults with Schizophrenia
GlobeNewswire Inc.27d ago
ImmunityBio, Inc. (IBRX) Investors: May 26, 2026, Filing Deadline in Securities Fraud Class Action - Contact Kessler Topaz Meltzer & Check, LLP
GlobeNewswire Inc.27d ago
REGENXBIO DEADLINE: ROSEN, A LEADING AND RANKED FIRM, Encourages REGENXBIO, Inc. Investors with Losses in Excess of $100K to Secure Counsel Before Important April 14 Deadline in Securities Class Action - RGNX
GlobeNewswire Inc.27d ago
ROSEN, GLOBAL INVESTOR COUNSEL, Encourages Aldeyra Therapeutics, Inc. Investors with Losses in Excess of $100K to Secure Counsel Before Important Deadline in Securities Class Action First Filed by the Firm - ALDX
Market Sentiment
Bullish
63% Sentiment Score
Sector Stats
Total Stocks217
News Today9
Avg Volume1.6M
AI SentimentBullish